Sanofi Completes Acquisition of Dynavax, Expands Adult Vaccine Portfolio with HEPLISAV-B
Sanofi has finalised its acquisition of Dynavax, adding hepatitis B vaccine HEPLISAV-B and a shingles vaccine candidate to strengthen its global adult immunisation business.
Hepatitis B Vaccine | 12/02/2026 | By News Bureau | 196
Sanofi to Acquire Dynavax, Expanding Vaccine Portfolio
Sanofi has agreed to acquire Dynavax, strengthening its adult immunisation portfolio with an approved hepatitis B vaccine and a shingles vaccine candidate in phase I/II development. The deal combines Dynavax’s vaccine assets with Sanofi’s global development and commercial capabilities.
Hepatitis B Vaccine | 24/12/2025 | By News Bureau | 124
Pharma giant GSK to build Singapore facility making Hepatitis B vaccine
Pharma giant GSK to build Singapore facility making Hepatitis B vaccine
Hepatitis B Vaccine | 14/07/2023 | By Sudeep Soparkar | 879
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy